{"name":"Uteron Pharma S.A.","slug":"uteron-pharma-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Levosert-20","genericName":"Levosert-20","slug":"levosert-20","indication":"Contraception","status":"phase_3"}]}],"pipeline":[{"name":"Levosert-20","genericName":"Levosert-20","slug":"levosert-20","phase":"phase_3","mechanism":"Levosert-20 is a levonorgestrel-releasing intrauterine system designed to provide long-acting contraception and reduce menstrual bleeding.","indications":["Contraception","Reduction of menorrhagia (heavy menstrual bleeding)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPRUdtbzZFNG1JWXF1cnR0aDRfWDNVUTdFOTROV0VEaDNwVW9FemdHN1dPSHlvWnF1Tkc2bVhFMTctQUN2UXB6ZkZNNzV6WHB0dTNDaW80WERyLVRSUEFWenpOcS1PTzBJN0xTbjcwT3VVMmZqQVIxRWVZR3AzdzhkdExwcnhrQTlTekZpOUpVckEtQQ?oc=5","date":"2013-01-23","type":"deal","source":"prnewswire.com","summary":"Watson Acquires Uteron Pharma SA - prnewswire.com","headline":"Watson Acquires Uteron Pharma SA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOWnFta2ZHNi1NTWNTc0VTSkFRRVZzNk9aX0dWYUhGbi1weU5hQ1pZZUVNSjJOanE0ZERmdnBsSFJRMGhrS1BNRWptMUYzNVN0MEhCci1vaHJFY0o2MktwMjQybk1nMlg5WVVKamY4Z3kwX3dad01qRWlYTGlsRFdHWg?oc=5","date":"2013-01-23","type":"deal","source":"Contract Pharma","summary":"Watson Acquires Uteron Pharma - Contract Pharma","headline":"Watson Acquires Uteron Pharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}